5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow brodalumab: new trials by email Literature Review of brodalumab trials Research Report on brodalumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Clinical Study of KHK4827 KHK4827, Placebo - Moderate to Severe Plaque Psoriasis | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 140 | 2012-12-01 | 2013-09-05 |
| A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma AMG 827, Placebo - Asthma | Phase 2 | Completed | Amgen | 315 | 2010-10-04 | 2021-11-26 |
| Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate Brodalumab, Placebo, Methotrexate - Rheumatoid Arthritis | Phase 2 | Completed | Amgen | 252 | 2009-12-30 | 2021-12-21 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis 70 mg SC, 210 mg SC, 140 mg SC - Psoriasis | Phase 2 | Completed | Bausch Health Americas, Inc. | 198 | 2009-12-01 | 2019-06-26 |
| Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis Brodalumab, Placebo - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Amgen | 40 | 2008-10-27 | 2021-11-26 |
Arthritis, Rheumatoid (2) · Arthritis (1) · Asthma (1) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Psoriasis (1) · Respiratory Sounds (1) · Rheumatic Diseases (1)
Amgen (3) · Bausch Health Americas, Inc. (1) · Kyowa Kirin Co., Ltd. (1)
Austria (1) · Belgium (1) · Canada (1) · Finland (1) · Hungary (1) · Japan (1) · Netherlands (1) · Poland (1) · Russia (1) · South Korea (1) · United States (1)